Last reviewed · How we verify
ProTrans: Allogeneic transplantation with WJMSCs
At a glance
| Generic name | ProTrans: Allogeneic transplantation with WJMSCs |
|---|---|
| Also known as | Protrans |
| Sponsor | NextCell Pharma Ab |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Wharton´s Jelly Derived Mesenchymal Stromal Cell Repeated Treatment of Adult Patients Diagnosed with Type I Diabetes (PHASE1, PHASE2)
- Wharton´s Jelly Derived Mesenchymal Stromal Cell Treatment of Adult Patients Diagnosed With Type I Diabetes (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |